Kristian Bjøro

• Fosby, Bjarte; Melum, Espen; Bjøro, Kristian; Bennet, William; Rasmussen, Allan & Andersen, Ina Riise [Show all 30 contributors for this article] (2015). Liver transplantation in the Nordic countries-An intention to treat and post-transplant analysis from the Nordic Liver Transplant Registry 1982-2013. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 50(6), p. 797–808. doi: 10.3109/00365521.2015.1036359. Full text in Research Archive
• Dalgard, Olav; Martinot-Peignoux, Michelle; Verbaan, Hans; Bjøro, Kristian; Ring-Larsen, Helmer & Marcellin, Patrick (2015). The usefulness of defining rapid virological response by a very sensitive assay (TMA) during treatment of HCV genotype 2/3 infection. PLOS ONE. 10(8). doi: 10.1371/journal.pone.0120866. Full text in Research Archive
• Eskesen, Arne N; Bjøro, Kristian; Aandahl, Einar Martin; Line, Pål Dag & Melum, Espen (2014). Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway-A population-based cohort study. Cancer Epidemiology. ISSN 1877-7821. 38(6), p. 741–747. doi: 10.1016/j.canep.2014.10.005. Full text in Research Archive
• Eskesen, Arne N; Melum, Espen; Moghaddam, Amir; Bjøro, Kristian; Verbaan, Hans & Ring-Larsen, Helmer [Show all 7 contributors for this article] (2012). Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort. European Journal of Gastroenterology and Hepathology. ISSN 0954-691X. 24(8), p. 890–896. doi: 10.1097/MEG.0b013e3283546efd. Full text in Research Archive
• Moghaddam, Amir; Melum, Espen; Reinton, Nils; Ring-Larsen, Helmer; Verbaan, Hans & Bjøro, Kristian [Show all 7 contributors for this article] (2011). IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection. Hepatology. ISSN 0270-9139. 53(3), p. 746–754. doi: 10.1002/hep.24154. Full text in Research Archive
• Dahl, Tuva Børresdatter; Haukeland, John Willy; Yndestad, Arne; Ranheim, Trine; Gladhaug, Ivar Prydz & Damås, Jan Kristian [Show all 16 contributors for this article] (2010). Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease. Journal of Clinical Endocrinology and Metabolism (JCEM). ISSN 0021-972X. 95(6), p. 3039–3047. doi: 10.1210/jc.2009-2148. Full text in Research Archive
• Dalgard, Olav; Bjøro, Kristian; Ring-Larsen, H. & Verbaan, H (2010). In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials. European Journal of Gastroenterology and Hepathology. ISSN 0954-691X. 22(5), p. 552–556. doi: 10.1097/MEG.0b013e328335b29e. Full text in Research Archive
• Haukeland, John Willy; Zbigniew, Konopski; Eggesbø, Heidi Beate; Volkmann, HL von; Raschpichler, G & Bjøro, Kristian [Show all 9 contributors for this article] (2009). Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 44(7), p. 853–860. doi: 10.1080/00365520902845268. Full text in Research Archive
• Haukeland, John Willy; Damås, Jan Kristian; Konopski, Zbigniew; Loberg, EM; Haaland, T & Goverud, I [Show all 10 contributors for this article] (2006). Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. Journal of Hepatology. ISSN 0168-8278. 44(6), p. 1167–1174. Full text in Research Archive
• Haukeland, John Willy; Zbigniew, Konopski; Linnestad, P.; Azimy, S.; Løberg, Else Marit & Haaland, T. [Show all 8 contributors for this article] (2005). Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 40(12), p. 1469–77. Full text in Research Archive
• Brandsæter, Bjørn Jardar; Schrumpf, Erik; Bentdal, Øystein H.; Braband, Knut; Smith, Hans-Jørgen & Abildgaard, Andreas [Show all 8 contributors for this article] (2005). Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver transplantation. ISSN 1527-6465. 11(11), p. 1361–1369. Full text in Research Archive
• Dalgaard, O; Bjøro, Kristian; Hellum, K Block; Myrvang, B; Ritland, S & Skaug, K [Show all 8 contributors for this article] (2004). Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 og 3 for 14 weeks: a pilot study. Hepatology. ISSN 0270-9139. 40, p. 1260–1265. Full text in Research Archive
• Bjøro, Kristian; Schou, IH; Smeby, Nina Aarhus & Hamilton, G (2004). A strategy for establishing hospital based Nursing Research in Norway. Vård i Norden. ISSN 0107-4083. 24(1), p. 42–44. Full text in Research Archive
• Brandsæter, Bjørn Jardar; Schrumpf, Erik; Clausen, Ole Petter Fraas; Abildgaard, Andreas; Hafsahl, Geir & Bjøro, Kristian (2004). Recurrent sclerosing cholangitis or ischemic bile duct lesions - a diagnostic challenge? Liver transplantation. ISSN 1527-6465. 10(8), p. 1073–1074. Full text in Research Archive
• Brandsæter, Bjørn Jardar; Isoniemi, H; Broome, U; Olausson, M; Backman, L & Hansen, B [Show all 14 contributors for this article] (2004). "Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy". Journal of Hepatology. ISSN 0168-8278. 40, p. 815–822. Full text in Research Archive
• Rokkones, Erik; Fromm, Sigurd H.; Kareem, Najma B.; Klungland, Helge; Olstad, Ole K. & Høgset, Anders [Show all 9 contributors for this article] (1995). Human Parathyroid Hormone as a Secretory Peptide in Milk of Transgenic Mice. Journal of Cellular Biochemistry. ISSN 0730-2312. 59, p. 168–176. Full text in Research Archive

View all works in NVA

• Røise, Olav; Fosse, Erik Torgeir; Aukrust, Pål; Emblem, Ragnhild; Bjøro, Kristian & Johansen, Stian Øby [Show all 9 contributors for this article] (2025). Ny lov om helseforskning kan true sikkerheten til pasientene. Full text in Research Archive Show summary

  Forskning er viktig for at vi skal kunne gi best mulig behandling. Men forslaget til ny helseforskningslov kan bidra til dårligere kvalitet på forskningen og svekket pasientsikkerhet.

• Jørgensen, Silje Fjellgård; Macpherson, Magnhild E; Bjøro, Kristian; Karlsen, Tom Hemming; Reims, Henrik Mikael & Grzyb, Krzysztof [Show all 10 contributors for this article] (2016). Liver transplantation in patients with primary antibody deficiency. Journal of Allergy and Clinical Immunology. ISSN 0091-6749. doi: 10.1016/j.jaci.2016.10.025. Full text in Research Archive
• Dalgard, Olav; Moghaddam, Amir; Verbaan, Hans; Ring-Larsen, Helmer; Bjøro, Kristian & Melum, Espen (2010). IL28B GENETIC VARIATION AND TREATMENT RESPONSE IN PATIENTS WITH HCV GENOTYPE 3 INFECTION. Hepatology. ISSN 0270-9139. 52(4), p. 751A–751A. Full text in Research Archive
• Bjøro, Kristian (2010). This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 45(6), p. 643–644. doi: 10.3109/00365521.2010.488881. Full text in Research Archive
• Carvalho, RJ; Verbaan, H; Bjøro, Kristian; Ring-Larsen, H & Dalgard, O (2009). LOW-TO-MODERATE ALCOHOL CONSUMPTION HAS NO IMPACT ON ANTIVIRAL RESPONSE TO COMBINATION THERAPY IN HCV PATIENTS WITH GENOTYPE 2 OR 3. Hepatology. ISSN 0270-9139. 50(4), p. 687A–688A. Full text in Research Archive
• Dalgard, Odd Steffen; Bjøro, Kristian; Ring-Larsen, H & Verbaan, H (2008). Is sustained virological response to HCV treatment associated with a clinical important improvement in vitality? Journal of Hepatology. ISSN 0168-8278. 48, p. S272–S272. Full text in Research Archive
• Haukeland, John Willy; Zbigniew, Konopski; Loberg, EM; Haaland, Therese Kristina; Volkmann, HL von & Raschpichler, G [Show all 9 contributors for this article] (2008). A RANDOMIZED, PLACEBO CONTROLLED TRIAL WITH METFORMIN IN PATIENTS WITH NAFLD. Hepatology. ISSN 0270-9139. 48(4), p. 334A–334A. Full text in Research Archive
• Dalgard, Olav; Verbaan, H; Ring-Larsen, H & Bjøro, Kristian (2008). IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS. Hepatology. ISSN 0270-9139. 48(4), p. 1148A–1148A. Full text in Research Archive
• Schrumpf, Erik & Bjøro, Kristian (2008). Timing of liver transplantation in PSC. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 43, p. 31–31. Full text in Research Archive
• Dalgard, O; Bjøro, Kristian; Hellum, K; Myrvang, B; Ritland, S & Skaug, K [Show all 8 contributors for this article] (2004). Short (14 weeks) treatment with pegylated interferon alpha-2B and ribavirin in patients with hepatitis C genotype 2/3 virus infection and early virological response. Hepatology. ISSN 0270-9139. 40, p. 252A–252A. Full text in Research Archive

View all works in NVA